(+)-epicatechin-3-O-gallate multiple interactions ISO RGD:732507 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of CRY2 mRNA] CTD PMID:29061316 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732507 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of CRY2 mRNA] CTD PMID:29061316 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1558359 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1558359 6480464 Tetrachlorodibenzodioxin results in increased expression of CRY2 mRNA CTD PMID:18295293 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRY2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1558359 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558359 6480464 Tetrachlorodibenzodioxin affects the expression of CRY2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CRY2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558359 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRY2 mRNA CTD PMID:21354282 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1558359 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1558359 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CRY2 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732507 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CRY2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO RGD:1558359 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CRY2 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1558359 6480464 4-hydroxy-2-nonenal results in decreased expression of CRY2 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide decreases expression ISO RGD:1558359 6480464 Fenretinide results in decreased expression of CRY2 mRNA CTD PMID:28973697 aflatoxin B1 decreases expression ISO RGD:732507 6480464 Aflatoxin B1 results in decreased expression of CRY2 mRNA CTD PMID:22100608 all-trans-retinoic acid increases expression ISO RGD:732507 6480464 Tretinoin results in increased expression of CRY2 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CRY2 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CRY2 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:732507 6480464 Antirheumatic Agents results in increased expression of CRY2 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:732507 6480464 Arsenic Trioxide results in increased expression of CRY2 mRNA CTD PMID:20458559 atrazine increases expression ISO RGD:732507 6480464 Atrazine results in increased expression of CRY2 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:732507 6480464 Benzo(a)pyrene results in decreased expression of CRY2 mRNA CTD PMID:32234424 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1558359 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CRY2 mRNA CTD PMID:26496021 bisphenol A multiple interactions ISO RGD:732507 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CRY2 mRNA CTD PMID:28628672 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CRY2 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1558359 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CRY2 mRNA CTD PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CRY2 mRNA CTD PMID:25181051 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CRY2 mRNA CTD PMID:19167457 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of CRY2, Cadmium Chloride affects the expression of CRY2 mRNA CTD PMID:21442002 , PMID:23085516 cadmium dichloride multiple interactions EXP 6480464 Melatonin affects the reaction [Cadmium Chloride affects the expression of CRY2] CTD PMID:23085516 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CRY2 mRNA CTD PMID:20107868 carbon nanotube decreases expression ISO RGD:1558359 6480464 Nanotubes, Carbon analog results in decreased expression of CRY2 mRNA, Nanotubes, Carbon results in decreased expression of CRY2 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1558359 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CRY2 gene CTD PMID:20938992 cobalt dichloride decreases expression ISO RGD:732507 6480464 cobaltous chloride results in decreased expression of CRY2 mRNA CTD PMID:20105288 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CRY2 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:732507 6480464 cobaltous chloride results in increased expression of CRY2 mRNA CTD PMID:19320972 cocaine decreases expression ISO RGD:1558359 6480464 Cocaine results in decreased expression of CRY2 mRNA CTD PMID:15994025 cyclosporin A increases expression ISO RGD:732507 6480464 Cyclosporine results in increased expression of CRY2 mRNA CTD PMID:25562108 cypermethrin increases expression ISO RGD:1558359 6480464 cypermethrin results in increased expression of CRY2 mRNA CTD PMID:21142847 dexamethasone multiple interactions ISO RGD:732507 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CRY2 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:732507 6480464 Arsenic Trioxide results in increased expression of CRY2 mRNA CTD PMID:20458559 dibenz[a,h]anthracene increases expression ISO RGD:1558359 6480464 1 more ... CTD PMID:26377693 dichloromethane increases expression ISO RGD:1558359 6480464 Methylene Chloride results in increased expression of CRY2 mRNA CTD PMID:28392392 doxorubicin decreases expression ISO RGD:732507 6480464 Doxorubicin results in decreased expression of CRY2 mRNA CTD PMID:29803840 ethanol multiple interactions ISO RGD:1558359 6480464 Ethanol affects the expression of and affects the splicing of CRY2 mRNA CTD PMID:30319688 finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of CRY2 mRNA CTD PMID:24136188 fluoxetine decreases expression ISO RGD:1558359 6480464 Fluoxetine results in decreased expression of CRY2 mRNA CTD PMID:15994025 folic acid multiple interactions ISO RGD:1558359 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CRY2 gene CTD PMID:20938992 gallic acid multiple interactions ISO RGD:732507 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of CRY2 mRNA] CTD PMID:29061316 gallocatechin multiple interactions ISO RGD:732507 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of CRY2 mRNA] CTD PMID:29061316 hydrogen peroxide affects expression ISO RGD:732507 6480464 Hydrogen Peroxide affects the expression of CRY2 mRNA CTD PMID:29061316 , PMID:30316844 hydrogen peroxide multiple interactions ISO RGD:732507 6480464 [Gallic Acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [Hydrogen Peroxide affects the expression of CRY2 mRNA], Polyphenols affects the reaction [Hydrogen Peroxide affects the expression of CRY2 mRNA] CTD PMID:29061316 , PMID:30316844 indometacin multiple interactions ISO RGD:732507 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CRY2 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1558359 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CRY2 gene CTD PMID:20938992 melatonin affects expression EXP 6480464 Melatonin affects the expression of CRY2 mRNA CTD PMID:21442002 melatonin multiple interactions EXP 6480464 Melatonin affects the reaction [Cadmium Chloride affects the expression of CRY2], Melatonin affects the reaction [Rotenone affects the expression of CRY2 mRNA] CTD PMID:23085516 , PMID:25430725 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CRY2 mRNA CTD PMID:23358140 paracetamol increases expression ISO RGD:732507 6480464 Acetaminophen results in increased expression of CRY2 mRNA CTD PMID:21420995 pirinixic acid increases expression ISO RGD:1558359 6480464 pirinixic acid results in increased expression of CRY2 mRNA CTD PMID:17426115 potassium dichromate decreases expression ISO RGD:1558359 6480464 Potassium Dichromate results in decreased expression of CRY2 mRNA CTD PMID:23608068 propiconazole decreases expression ISO RGD:1558359 6480464 propiconazole results in decreased expression of CRY2 mRNA CTD PMID:21278054 rotenone multiple interactions EXP 6480464 Melatonin affects the reaction [Rotenone affects the expression of CRY2 mRNA] CTD PMID:25430725 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CRY2 mRNA CTD PMID:28374803 rotenone affects expression EXP 6480464 Rotenone affects the expression of CRY2 mRNA CTD PMID:25430725 Se-methyl-L-selenocysteine increases expression EXP 6480464 selenomethylselenocysteine results in increased expression of CRY2 mRNA CTD PMID:19122877 Se-methylselenocysteine increases expression EXP 6480464 selenomethylselenocysteine results in increased expression of CRY2 mRNA CTD PMID:19122877 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of CRY2 mRNA CTD PMID:15967596 silicon dioxide increases expression ISO RGD:732507 6480464 Silicon Dioxide results in increased expression of CRY2 mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:1558359 6480464 Silver results in increased expression of CRY2 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1558359 6480464 Silver results in increased expression of CRY2 mRNA CTD PMID:27131904 Soman increases expression EXP 6480464 Soman results in increased expression of CRY2 mRNA CTD PMID:19281266 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of CRY2 mRNA CTD PMID:24136188 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of CRY2 mRNA CTD PMID:26496021 tetrachloroethene increases expression ISO RGD:1558359 6480464 Tetrachloroethylene results in increased expression of CRY2 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CRY2 mRNA CTD PMID:31150632 tetraphene increases expression ISO RGD:1558359 6480464 benz(a)anthracene results in increased expression of CRY2 mRNA CTD PMID:26377693 trichostatin A affects expression ISO RGD:732507 6480464 trichostatin A affects the expression of CRY2 mRNA CTD PMID:28542535 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CRY2 mRNA CTD PMID:30589522 valproic acid increases expression ISO RGD:1558359 6480464 Valproic Acid results in increased expression of CRY2 mRNA CTD PMID:29229235 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of CRY2 mRNA CTD PMID:23034163 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CRY2 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:1558359 6480464 vorinostat results in increased expression of CRY2 mRNA CTD PMID:29229235
Biological Process circadian regulation of gene expression ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:3843127 more ... RGD MGI:MGI:3843127 more ... circadian regulation of gene expression ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 circadian regulation of gene expression IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 circadian rhythm IEP 632584 RGD circadian rhythm ISO RGD:1558359 1624291 MGI:MGI:2181206 (MGI:MGI:2179885 more ... RGD MGI:MGI:2179885 more ... circadian rhythm ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 entrainment of circadian clock by photoperiod ISO RGD:1558359 1624291 (MGI:MGI:5490394, PMID:23616524) RGD MGI:MGI:5490394 , PMID:23616524 entrainment of circadian clock by photoperiod ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 entrainment of circadian clock by photoperiod IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 glucose homeostasis ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:5302136 , PMID:22170608) RGD MGI:MGI:5302136 , PMID:22170608 glucose homeostasis ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 glucose homeostasis IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 lipid storage ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:5495865 , PMID:23531614) RGD MGI:MGI:5495865 , PMID:23531614 lipid storage IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of circadian rhythm ISO RGD:1558359 1624291 (MGI:MGI:4410413, PMID:19605937) RGD MGI:MGI:4410413 , PMID:19605937 negative regulation of circadian rhythm ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of circadian rhythm IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of glucocorticoid receptor signaling pathway ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:5302136 , PMID:22170608) RGD MGI:MGI:5302136 , PMID:22170608 negative regulation of glucocorticoid receptor signaling pathway ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of glucocorticoid receptor signaling pathway IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of glucocorticoid secretion ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:5495865 , PMID:23531614) RGD MGI:MGI:5495865 , PMID:23531614 negative regulation of glucocorticoid secretion IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 negative regulation of phosphoprotein phosphatase activity ISO RGD:732507 1624291 (PMID:9383998) RGD PMID:9383998 negative regulation of transcription by RNA polymerase II ISO RGD:732507 1624291 (PMID:12397359), (PMID:14672706), (PMID:15147242) RGD PMID:12397359 more ... negative regulation of transcription, DNA-templated ISO RGD:732507 1624291 (PMID:12397359) RGD PMID:12397359 negative regulation of transcription, DNA-templated ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:4410413 more ... RGD MGI:MGI:4410413 more ... negative regulation of transcription, DNA-templated ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 negative regulation of transcription, DNA-templated IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 photoreactive repair NOT ISO RGD:732507 1624291 (PMID:12627958) RGD PMID:12627958 protein import into nucleus ISO RGD:1558359 1624291 PR:O54943 (MGI:MGI:3579718, PMID:15689618) RGD MGI:MGI:3579718 , PMID:15689618 protein import into nucleus IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein-chromophore linkage IEA UniProtKB-KW:KW-0157 1600115 GO_REF:0000043 UniProt GO_REF:0000043 regulation of circadian rhythm ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:1334825 more ... RGD MGI:MGI:1334825 more ... regulation of circadian rhythm ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 regulation of sodium-dependent phosphate transport ISO RGD:732507 1624291 (PMID:9753616) RGD PMID:9753616 response to activity ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 response to activity ISO RGD:1558359 1624291 (MGI:MGI:6107163, PMID:28683290) RGD MGI:MGI:6107163 , PMID:28683290 response to activity IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to insulin ISO RGD:1558359 1624291 UniProtKB:P97784 (MGI:MGI:5495865 , PMID:23531614) RGD MGI:MGI:5495865 , PMID:23531614 response to insulin IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 response to light stimulus ISO RGD:732507 1624291 (PMID:15751956) RGD PMID:15751956 response to light stimulus ISO RGD:1558359 1624291 (MGI:MGI:6294193, PMID:29561690) RGD MGI:MGI:6294193 , PMID:29561690 response to light stimulus ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 Cellular Component cytosol IEA UniProtKB:A0A0D2X7Z3 , ensembl:ENSP000004781871600115 GO_REF:0000107 Ensembl GO_REF:0000107 cytosol ISO RGD:732507 1624291 RGD GO_REF:0000052 extracellular region ISO RGD:732507 1624291 (PMID:9753616) RGD PMID:9753616 mitochondrion ISO RGD:1558359 1624291 (MGI:MGI:1314997, PMID:9801304) RGD MGI:MGI:1314997 , PMID:9801304 mitochondrion IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 nuclear speck IEA UniProtKB:A0A0D2X7Z3 , ensembl:ENSP000004781871600115 GO_REF:0000107 Ensembl GO_REF:0000107 nuclear speck ISO RGD:732507 1624291 RGD GO_REF:0000052 nucleus ISO RGD:1558359 1624291 (MGI:MGI:1314997 more ... RGD MGI:MGI:1314997 more ... nucleus ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 Molecular Function damaged DNA binding ISO RGD:732507 1624291 (PMID:12627958) RGD PMID:12627958 deoxyribodipyrimidine photo-lyase activity NOT ISO RGD:732507 1624291 (PMID:8909283) RGD PMID:8909283 DNA (6-4) photolyase activity NOT ISO RGD:732507 1624291 (PMID:8909283) RGD PMID:8909283 DNA binding ISO RGD:732507 1624291 (PMID:12627958) RGD PMID:12627958 FAD binding ISO RGD:1558359 1624291 (MGI:MGI:5508675, PMID:23503662) RGD MGI:MGI:5508675 , PMID:23503662 FAD binding ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 FAD binding IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 kinase binding ISO RGD:1558359 1624291 UniProtKB:P97313 (MGI:MGI:5554971 , PMID:24158435) RGD MGI:MGI:5554971 , PMID:24158435 lyase activity IEA UniProtKB-KW:KW-0456 1600115 GO_REF:0000043 UniProt GO_REF:0000043 nuclear hormone receptor binding ISO RGD:1558359 1624291 UniProtKB:P04150 more ... RGD MGI:MGI:5302136 , PMID:22170608 nuclear hormone receptor binding IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 phosphatase binding ISO RGD:732507 1624291 UniProtKB:P53041 (PMID:9383998) RGD PMID:9383998 photoreceptor activity IEA UniProtKB-KW:KW-0600 1600115 GO_REF:0000043 UniProt GO_REF:0000043 protein binding ISO RGD:732507 1624291 UniProtKB:A8MQ03 more ... RGD PMID:16790549 more ... protein binding ISO RGD:1558359 1624291 PR:O35343 more ... RGD MGI:MGI:3027197 more ... protein kinase binding ISO RGD:1558359 1624291 UniProtKB:Q61214 more ... RGD MGI:MGI:4461092 , PMID:20123978 protein kinase binding IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107 single-stranded DNA binding ISO RGD:732507 1624291 (PMID:12627958) RGD PMID:12627958 transcription regulatory region sequence-specific DNA binding ISO RGD:1558359 1624291 (MGI:MGI:5014424, PMID:21680841) RGD MGI:MGI:5014424 , PMID:21680841 transcription regulatory region sequence-specific DNA binding ISS UniProtKB:Q9R194 1600115 GO_REF:0000024 UniProt GO_REF:0000024 transcription regulatory region sequence-specific DNA binding IEA UniProtKB:Q9R194 , ensembl:ENSMUSP000000880471600115 GO_REF:0000107 Ensembl GO_REF:0000107
Gene-Chemical Interaction Annotations
